Comparison_NN between_IN the_DT Skin_NP Snip_NP Test_NP and_CC Simple_NP Dot_NP Blot_NP Assay_NP as_IN Potential_JJ Rapid_NP Assessment_NP Tools_NP for_IN Onchocerciasis_NP in_IN the_DT Postcontrol_NP Era_NP in_IN Ghana_NP Successful_NP control_NN of_IN onchocerciasis_NN through_IN mass_JJ distribution_NN of_IN ivermectin_NN needs_VBZ to_TO be_VB coupled_VBN with_IN reliable_JJ ,_, sensitive_JJ ,_, specific_JJ ,_, yet_RB affordable_JJ diagnostic_JJ methods_NNS to_TO monitor_VB and_CC ensure_VB the_DT efficacy_NN of_IN such_JJ measures_NNS ._SENT The_DT effort_NN put_VBN into_IN the_DT development_NN of_IN diagnostic_JJ methods_NNS for_IN onchocerciasis_NN that_WDT can_MD substitute_VB for_IN or_CC work_VB in_IN combination_NN with_IN the_DT present_JJ "_`` gold_NN standard_NN ,_, "_'' the_DT skin_NN snip_NN test_NN ,_, has_VBZ resulted_VBN in_IN the_DT discovery_NN of_IN a_DT number_NN of_IN immunogenic_JJ proteins_NNS with_IN potential_JJ use_NN as_IN diagnostic_JJ tools_NNS in_IN the_DT postcontrol_NN era_NN ._SENT Most_JJS of_IN these_DT proteins_NNS have_VBP now_RB been_VBN produced_VBN through_IN recombinant_JJ DNA_NN techniques_NNS ._SENT However_RB ,_, when_WRB costs_NNS are_VBP not_RB a_DT trivial_JJ issue_NN ,_, none_NN of_IN them_PP have_VBP yet_RB found_VBN their_PP$ way_NN into_IN the_DT areas_NNS where_WRB the_DT disease_NN still_RB exists_VBZ ._SENT In_IN the_DT present_JJ study_NN ,_, we_PP have_VBP evaluated_VBN the_DT performance_NN of_IN a_DT simple_JJ dot_NN blot_NN assay_NN which_WDT uses_VBZ a_DT mixture_NN of_IN native_JJ proteins_NNS designated_VBN PakF_NP as_IN a_DT serious_JJ contender_NN in_IN the_DT quest_NN for_IN a_DT less_RBR invasive_JJ and_CC more_RBR sensitive_JJ method_NN to_TO detect_VB Onchocerca_NP volvulus_NN infection_NN in_IN areas_NNS with_IN diverse_JJ endemicities_NNS ._SENT Our_PP$ results_NNS indicate_VBP that_IN the_DT assay_NN we_PP propose_VBP is_VBZ more_RBR sensitive_JJ than_IN the_DT skin_NN snip_NN test_NN and_CC shows_VBZ high_JJ specificity_NN ,_, both_CC characteristics_NNS required_VBN for_IN a_DT suitable_JJ tool_NN for_IN the_DT monitoring_NN of_IN onchocerciasis_NN in_IN the_DT postcontrol_NN era_NN ._SENT Onchocerciasis_NP (_( river_NN blindness_NN )_) occurs_VBZ in_IN 34_CD countries_NNS in_IN Africa_NP ,_, Latin_NP America_NP ,_, and_CC the_DT Arabian_NP Peninsula_NP ._SENT The_DT vast_JJ majority_NN of_IN the_DT estimated_VBN 18_CD million_CD persons_NNS infected_VBN with_IN the_DT causative_JJ agent_NN ,_, the_DT parasite_NN Onchocerca_NP volvulus_NN ,_, live_JJ in_IN Africa_NP ._SENT One_CD of_IN the_DT goals_NNS of_IN the_DT World_NP Health_NP Organization_NP is_VBZ to_TO eliminate_VB onchocerciasis_NN as_IN a_DT public_JJ health_NN problem_NN ._SENT The_DT classical_JJ method_NN to_TO detect_VB O._NP volvulus_NN infection_NN consists_VBZ of_IN examining_VBG small_JJ skin_NN biopsy_NN specimens_NNS (_( skin_NN snips_NNS )_) by_IN microscopy_NN for_IN the_DT presence_NN of_IN O._NP volvulus_NN microfilariae_NNS (_( mf_NN )_) ._SENT However_RB ,_, this_DT very_RB specific_JJ method_NN is_VBZ invasive_JJ ._SENT The_DT process_NN may_MD be_VB uncomfortable_JJ ,_, which_WDT may_MD result_VB in_IN poor_JJ compliance_NN from_IN individuals_NNS ,_, especially_RB in_IN communities_NNS subjected_VBN to_TO repeated_JJ tests_NNS ._SENT Much_JJ effort_NN has_VBZ been_VBN put_VBN into_IN the_DT development_NN of_IN less_JJR invasive_JJ serodiagnostic_JJ methods_NNS to_TO support_VB the_DT initiatives_NNS aimed_VBN at_IN elimination_NN of_IN the_DT disease_NN ._SENT The_DT program_NN in_IN West_NP Africa_NP ,_, known_VBN as_IN the_DT Onchocerciasis_NP Control_NP Program_NP (_( OCP_NP )_) ,_, has_VBZ been_VBN successful_JJ in_IN meeting_VBG its_PP$ goal_NN of_IN eliminating_VBG onchocerciasis_NN as_IN a_DT public_JJ health_NN problem_NN in_IN the_DT 11_CD countries_NNS where_WRB the_DT program_NN has_VBZ been_VBN active_JJ ._SENT As_IN a_DT result_NN of_IN the_DT OCP_NP 's_POS success_NN ,_, the_DT efforts_NNS of_IN the_DT program_NN are_VBP now_RB turning_VBG to_TO surveillance_NN ,_, with_IN the_DT goal_NN of_IN rapidly_RB detecting_VBG and_CC controlling_VBG outbreaks_NNS of_IN infection_NN in_IN the_DT onchocerciasis-free_JJ zones_NNS ._SENT In_IN the_DT postivermectin_NN era_NN ,_, however_RB ,_, there_EX is_VBZ still_RB no_DT diagnostic_JJ test_NN available_JJ for_IN large-scale_JJ use_NN in_IN onchocerciasis-free_JJ zones_NNS or_CC areas_NNS where_WRB the_DT disease_NN is_VBZ still_RB endemic_JJ ,_, although_IN with_IN very_RB low_JJ mf_NN density_NN ._SENT We_PP have_VBP previously_RB described_VBN a_DT simple_JJ dot_NN blot_NN assay_NN (_( DBA_NP )_) using_VBG a_DT native_JJ low-molecular-weight_JJ antigen_NN fraction_NN of_IN female_JJ O._NP volvulus_NN parasites_NNS ,_, designated_VBN PakF_NP ,_, which_WDT is_VBZ a_DT useful_JJ diagnostic_JJ test_NN in_IN settings_NNS where_WRB the_DT disease_NN is_VBZ nonendemic_JJ ,_, and_CC with_IN its_PP$ high_JJ specificity_NN and_CC sensitivity_NN ,_, it_PP could_MD have_VB potential_JJ as_IN a_DT screening_NN tool_NN for_IN onchocerciasis_NN under_IN certain_JJ circumstances_NNS ._SENT The_DT DBA_NP using_VBG this_DT antigenic_JJ fraction_NN (_( PakF-DBA_NP )_) showed_VBD very_RB high_JJ sensitivity_NN and_CC specificity_NN when_WRB tested_VBN in_IN Guatemala_NP (_( 9a_NP )_) ,_, a_DT country_NN where_WRB onchocerciasis_NN is_VBZ endemic_JJ but_CC where_WRB no_DT other_JJ human_JJ filariasis_NN has_VBZ been_VBN reported_VBN ._SENT In_IN this_DT study_NN ,_, we_PP describe_VBP the_DT evaluation_NN of_IN the_DT PakF-DBA_NP for_IN sera_NN from_IN individuals_NNS from_IN localities_NNS with_IN diverse_JJ endemicities_NNS in_IN the_DT Volta_NP region_NN of_IN Ghana_NP and_CC compare_VB the_DT results_NNS with_IN those_DT obtained_VBN using_VBG the_DT skin_NN snip_NN test_NN ._SENT This_DT region_NN of_IN Ghana_NP has_VBZ pockets_NNS of_IN high_JJ and_CC low_JJ transmission_NN of_IN onchocerciasis_NN ,_, and_CC mass_NN treatment_NN has_VBZ been_VBN practiced_VBN in_IN some_DT of_IN these_DT areas_NNS ._SENT Screening_VBG for_IN onchocerciasis_NN in_IN these_DT areas_NNS has_VBZ always_RB been_VBN done_VBN using_VBG the_DT skin_NN snip_NN test_NN ;_: however_RB ,_, repeated_JJ ivermectin_NN treatment_NN results_NNS in_IN decreased_VBN mf_NN load_NN ,_, making_VBG the_DT skin_NN snip_NN test_NN less_RBR sensitive_JJ and_CC reliable_JJ ._SENT We_PP also_RB evaluate_VB the_DT potential_JJ cross-reactivity_NN of_IN the_DT assay_NN with_IN other_JJ filarial_JJ infections_NNS and_CC show_VB that_DT sera_NN from_IN patients_NNS with_IN circulating_VBG Wuchereria_NP bancrofti_NNS do_VBP not_RB cross-react_VB in_IN this_DT assay_NN ._SENT We_PP discuss_VBP the_DT potential_JJ use_NN of_IN the_DT PakF-DBA_NP as_IN a_DT less_RBR expensive_JJ and_CC therefore_RB affordable_JJ method_NN for_IN rapid_JJ screening_NN and_CC monitoring_NN of_IN areas_NNS where_WRB control_NN measures_NNS have_VBP been_VBN established_VBN ._SENT (_( G._NP Guzman_NP conducted_VBD this_DT research_NN in_IN partial_JJ fulfillment_NN of_IN the_DT requirements_NNS for_IN his_PP$ Ph.D._NP thesis_NN at_IN Karolinska_NP Institute_NP ,_, Stockholm_NP ,_, Sweden_NP ,_, 2002_CD ._SENT )_) Study_NP population_NN ._SENT |_SYM The_DT study_NN was_VBD carried_VBN out_RP in_IN five_CD localities_NNS of_IN the_DT district_NN of_IN Ho_NP in_IN the_DT Volta_NP region_NN of_IN Ghana_NP with_IN diverse_JJ endemicities_NNS (_( hypo-_NN and_CC hyperendemicity_NN )_) ._SENT Thirty_CD individuals_NNS ,_, who_WP volunteered_VBD to_TO participate_VB ,_, were_VBD selected_VBN from_IN each_DT locality_NN ,_, half_DT of_IN whom_WP were_VBD within_IN the_DT age_NN range_NN of_IN 5_CD to_TO 17_CD years_NNS ._SENT Informed_JJ consent_NN was_VBD obtained_VBN from_IN all_PDT the_DT participants_NNS in_IN the_DT study_NN or_CC their_PP$ parents_NNS or_CC guardians_NNS ._SENT The_DT localities_NNS were_VBD as_RB follows_VBZ :_: (_( i_NP )_) Aflapke_NP (_( LOC1_NP ;_: male-to-female_JJ ratio_NN ,_, 0.9_CD ;_: child-to-adult_NN ratio_NN ,_, 1_CD )_) ,_, (_( ii_NP )_) Klave_NP (_( LOC2_NP ;_: male-to-female_JJ ratio_NN ,_, 0.9_CD ;_: child-to-adult_NN ratio_NN ,_, 1_CD )_) ,_, (_( iii_NP )_) Aboete_NN ,_, Anorme_NP ,_, Asifiafe_NP ,_, and_CC Luvudo_NP (_( LOC3_NP ;_: male-to-female_JJ ratio_NN ,_, 2.3_CD ;_: child-to-adult_NN ratio_NN ,_, 1_CD )_) ,_, (_( iv_NP )_) Honuta_NP Gborgame_NP (_( LOC4_NP ;_: male-to-female_JJ ratio_NN ,_, 0.8_CD ;_: child-to-adult_NN ratio_NN ,_, 1_CD )_) ,_, and_CC Kpedze_NP Anoe_NP (_( LOC5_NP ;_: male-to-female_JJ ratio_NN ,_, 1.0_CD ;_: child-to-adult_NN ratio_NN ,_, 1_CD )_) ._SENT Study_NN samples_NNS ._SENT |_SYM Capillary_NP blood_NN was_VBD obtained_VBN by_IN pricking_VBG the_DT middle_JJ finger_NN with_IN a_DT disposable_JJ hemolancet_NN ._SENT Five_CD circles_NNS of_IN blood_NN were_VBD blotted_VBN onto_IN previously_RB labeled_VBN 90-mm-diameter_NN round_NN ,_, fast-drying_VBG filter_NN paper_NN (_( no_UH ._SENT 597_LS ;_: Schleicher_NP &_CC Schuell_NP ,_, Dassel_NP ,_, Germany_NP )_) ._SENT When_WRB the_DT blood_NN spots_NNS were_VBD dry_JJ ,_, filters_NNS were_VBD placed_VBN inside_IN labeled_VBN plastic_JJ zip-lock_NN bags_NNS and_CC stored_VBN in_IN the_DT freezer_NN compartment_NN of_IN a_DT refrigerator_NN (_( approximate_JJ temperature_NN ,_, -20C_NP )_) ._SENT Blood_NN collection_NN was_VBD done_VBN according_VBG to_TO the_DT ethical_JJ and_CC safety_NN policies_NNS in_IN Ghana_NP ._SENT Pools_NNS of_IN sera_NN from_IN mf+_NN and_CC nonexposed_JJ Guatemalan_JJ individuals_NNS from_IN a_DT previous_JJ study_NN were_VBD used_VBN as_IN positive_JJ and_CC negative_JJ controls_NNS ,_, respectively_RB ._SENT A_DT panel_NN of_IN Indian_JJ sera_NN from_IN areas_NNS where_WRB W._NP bancrofti_NP is_VBZ endemic_JJ ,_, including_VBG 9_CD microfilaremic_JJ patients_NNS (_( W._NP bancrofti_NP mf+_NN ;_: age_NN range_NN ,_, 10_CD to_TO 40_CD years_NNS )_) and_CC 16_CD patients_NNS with_IN chronic_JJ infection_NN but_CC no_DT circulating_VBG mf_NN in_IN the_DT blood_NN (_( chronic_JJ patients_NNS [_SYM CP_NP ]_SYM ;_: age_NN range_NN ,_, 20_CD to_TO 50_CD years_NNS )_) ,_, were_VBD used_VBN as_IN other_JJ filaria_NN controls_NNS ._SENT In_IN addition_NN ,_, 15_CD individuals_NNS living_VBG in_IN the_DT same_JJ area_NN with_IN no_DT evidence_NN of_IN filariasis_NN (_( endemic_JJ controls_NNS [_SYM EN_NN ]_SYM )_) were_VBD included_VBN ._SENT These_DT sera_NN were_VBD from_IN an_DT area_NN where_WRB onchocerciasis_NN is_VBZ not_RB reported_VBN ._SENT Diagnosis_NN of_IN onchocerciasis_NN ._SENT |_SYM Parasitological_JJ examination_NN for_IN O._NP volvulus_NN was_VBD done_VBN by_IN four-site_JJ skin_NN snips_NNS and_CC microscopic_JJ examination_NN for_IN the_DT presence_NN of_IN mf_NN following_VBG 24-h_JJ incubation_NN in_IN saline_NN at_IN room_NN temperature_NN (_( approximately_RB 20C_JJ )_) ._SENT The_DT presence_NN of_IN mf_NN of_IN O._NP volvulus_NN in_IN any_DT of_IN the_DT skin_NN snips_NNS confirmed_VBD the_DT diagnosis_NN ._SENT Skilled_JJ technicians_NNS could_MD distinguish_VB O._NP volvulus_NN from_IN other_JJ filaria_NN ,_, such_JJ as_IN Streptocerca_NP ,_, which_WDT is_VBZ prevalent_JJ in_IN the_DT study_NN area_NN ._SENT The_DT microfilarial_JJ density_NN (_( MFD_NP )_) was_VBD determined_VBN by_IN dividing_VBG the_DT average_JJ number_NN of_IN mf_NN by_IN the_DT average_JJ weight_NN of_IN the_DT skin_NN snips_NNS in_IN milligrams_NNS ._SENT Thus_RB ,_, an_DT mf+_JJ diagnosis_NN corresponded_VBD to_TO an_DT individual_NN with_IN an_DT MFD_NN of_IN >0_NN ._SENT Antigen_NN preparation_NN (_( TSF_NP )_) ._SENT |_SYM Intact_NP noncalcified_JJ nodules_NNS obtained_VBN in_IN a_DT previous_JJ study_NN were_VBD digested_VBN by_IN the_DT collagenase_NN method_NN of_IN Schulz-Key_NP et_FW al._FW ._SENT Female_JJ worms_NNS were_VBD washed_VBN and_CC frozen_VBN at_IN -70C_NN in_IN RPMI_NP 1640_CD medium_NN containing_VBG gentamicin_NN (_( 0.2_CD mg/ml_NN )_) ._SENT Tris-soluble_JJ antigen_NN fractions_NNS (_( TSF_NP )_) were_VBD prepared_VBN as_IN previously_RB described_VBN and_CC stored_VBN at_IN -20C_NN ._SENT The_DT total_JJ protein_NN concentration_NN was_VBD estimated_VBN by_IN the_DT Bradford_NP assay_NN ._SENT IEC_NP ._SENT |_SYM PakF_NP fractions_NNS were_VBD prepared_VBN separately_RB from_IN TSF_NP by_IN ion-exchange_NN chromatography_NN (_( IEC_NP )_) as_RB described_VBD previously_RB ,_, except_IN that_WDT neither_CC a_DT fast_JJ protein_NN liquid_JJ chromatography_NN system_NN nor_CC a_DT peristaltic_JJ pump_NN was_VBD used_VBN ._SENT We_PP simplified_VBD the_DT IEC_NP preparation_NN by_IN using_VBG a_DT handheld_NN ion-exchange_NN column_NN as_RB described_VBD elsewhere_RB (_( unpublished_JJ data_NNS )_) ._SENT One_CD hundred_CD and_CC twelve_NN micrograms_NNS of_IN TSF_NP (_( 1_CD to_TO 1.3_CD mug/mul_NN )_) was_VBD diluted_VBN to_TO 0.5_CD ml_NN in_IN equilibration_NN buffer_NN (_( 50_CD mM_NP Tris-HCl_NP ,_, pH_NN 9.0_CD ,_, containing_VBG 0.05_CD %_NN Tween_NP 20_CD )_) ._SENT This_DT was_VBD passed_VBN manually_RB through_IN a_DT 1-ml_JJ HiTrap-Q_NP ionic_JJ column_NN (_( Pharmacia_NP ,_, Uppsala_NP ,_, Sweden_NP )_) at_IN a_DT flow_NN rate_NN of_IN 0.5_CD ml/min_NN using_VBG a_DT 1-ml_JJ syringe_NN as_IN a_DT reservoir_NN ._SENT The_DT sample_NN was_VBD eluted_VBN with_IN equilibration_NN buffer_NN at_IN 0.5_CD ml/min_NN ,_, and_CC the_DT eluate_NN was_VBD collected_VBN in_IN eight_CD 350-mul_JJ aliquots_NNS before_IN the_DT buffer_NN was_VBD changed_VBN to_TO equilibration_NN buffer_NN containing_VBG 0.5_CD M_NP NaCl_NP ._SENT Two_CD final_JJ 350-mul_JJ aliquots_NNS were_VBD collected_VBN using_VBG this_DT buffer_NN ._SENT Each_DT fraction_NN was_VBD tested_VBN for_IN antigenicity_NN and_CC polypeptide_NN composition_NN using_VBG a_DT DBA_NP (_( see_VB below_IN )_) and_CC one-dimensional_JJ gel_NN electrophoresis_NN as_IN previously_RB described_VBN ._SENT Serum_NN elution_NN from_IN blood_NN spots_NNS ._SENT |_SYM Blood_NP was_VBD extracted_VBN as_IN previously_RB described_VBN ._SENT Briefly_RB ,_, one_CD disk_NN ,_, 6_CD mm_NN in_IN diameter_NN ,_, was_VBD cut_VBN out_RP from_IN a_DT blood_NN blot_NN on_IN each_DT filter_NN and_CC extracted_VBN for_IN 2_CD h_NN in_IN 2_CD ml_NN of_IN phosphate-buffered_JJ saline_NN (_( PBS_NP ;_: pH_NN 7.4_CD )_) containing_VBG 0.05_CD %_NN Tween_NP 20_CD (_( PBST_NP )_) ._SENT After_IN slow_JJ vortexing_NN ,_, the_DT disk_NN was_VBD removed_VBN and_CC the_DT eluted_VBN serum_NN was_VBD collected_VBN ._SENT In_IN some_DT instances_NNS ,_, eluted_VBD sera_NN were_VBD tested_VBN before_IN and_CC after_IN heat_NN treatment_NN at_IN 56C_NN for_IN 30_CD min_NN ._SENT DBA_NP ._SENT |_SYM The_NP DBA_NP was_VBD performed_VBN as_IN described_VBN previously_RB with_IN some_DT modifications_NNS ._SENT Briefly_RB ,_, nitrocellulose_NN strips_NNS ,_, 4_CD mm_NN wide_JJ and_CC 3_CD cm_NN long_JJ ,_, were_VBD placed_VBN in_IN mini-incubation_NN trays_NNS (_( Bio-Rad_NP Laboratories_NP ,_, Richmond_NP ,_, Calif._NP )_) ,_, and_CC droplets_NNS (_( 0.5_CD mul_NN )_) of_IN unconcentrated_JJ and_CC undiluted_JJ PakF_NP (_( approximately_RB 5_CD ng_NNS )_) and_CC TSF_NP (_( 64_CD ng_NNS ;_: positive_JJ control_NN )_) were_VBD adsorbed_VBN on_IN the_DT strips_NNS ._SENT The_DT strips_NNS were_VBD allowed_VBN to_TO dry_VB at_IN room_NN temperature_NN and_CC were_VBD then_RB blocked_VBN with_IN 1_CD %_NN nonfat_NN milk_NN powder_NN in_IN PBST_NP for_IN 1_CD h_NN under_IN gentle_JJ agitation_NN on_IN a_DT rocking_VBG shaker_NN ._SENT The_DT strips_NNS were_VBD incubated_VBN for_IN 1_CD h_NN with_IN 1_CD ml_NN of_IN eluted_VBN serum_NN ._SENT The_DT strips_NNS were_VBD washed_VBN three_CD times_NNS for_IN 5_CD min_NN each_DT time_NN with_IN PBST_NP and_CC then_RB incubated_VBN for_IN 1_CD h_NN with_IN alkaline_JJ phosphatase-labeled_JJ goat_NN anti-human_NN immunoglobulin_NN G_NP (_( Calbiochem_NP ,_, La_NP Jolla_NP ,_, Calif._NP )_) diluted_VBD 1:2,000_CD in_IN PBST_NP ._SENT The_DT strips_NNS were_VBD washed_VBN three_CD times_NNS as_RB before_IN with_IN PBST_NP and_CC twice_RB with_IN PBS_NP only_RB before_IN development_NN of_IN the_DT immunoreactive_JJ spots_NNS with_IN BCIP_NP (5-bromo-4-chloro-3-indolylphosphate)-nitroblue_NN tetrazolium_NN (_( Sigma_NP Chemical_NP Co._NP ,_, St._NP Louis_NP ,_, Mo._NP )_) ._SENT The_DT color_NN reaction_NN was_VBD allowed_VBN to_TO proceed_VB for_IN 10_CD min_NN and_CC then_RB was_VBD stopped_VBN with_IN several_JJ washes_VBZ with_IN distilled_JJ water_NN ._SENT The_DT strips_NNS were_VBD air_NN dried_VBN in_IN the_DT dark_NN ._SENT The_DT DBA_NP was_VBD performed_VBN blind_JJ ,_, and_CC thus_RB the_DT results_NNS from_IN the_DT skin_NN snips_NNS were_VBD not_RB made_VBN available_JJ to_TO the_DT person_NN performing_VBG the_DT assay_NN until_IN after_IN all_PDT the_DT analyses_NNS had_VBD been_VBN done_VBN ._SENT Control_NN sera_NN were_VBD tested_VBN first_JJ ,_, diluted_JJ 1:4,000_CD in_IN PBST_NP ._SENT Evaluation_NN of_IN the_DT dot_NN blots_NNS ._SENT |_SYM Nitrocellulose_JJ strips_NNS were_VBD evaluated_VBN by_IN visual_JJ examination_NN and_CC ,_, for_IN purposes_NNS of_IN quantification_NN ,_, also_RB by_IN densitometry_NN ._SENT Densitometric_JJ values_NNS were_VBD obtained_VBN as_IN the_DT integrated_JJ intensity_NN of_IN all_PDT the_DT pixels_NNS in_IN a_DT spot_NN excluding_VBG the_DT background_NN and_CC were_VBD expressed_VBN as_IN arbitrary_JJ units_NNS (_( Bio_NP Image_NP ,_, Ann_NP Arbor_NP ,_, Mich._NP )_) ._SENT A_DT visually_RB positive_JJ sample_NN was_VBD determined_VBN by_IN identifying_VBG two_CD spots_NNS of_IN reactivity_NN where_WRB PakF_NP was_VBD applied_VBN to_TO the_DT nitrocellulose_NN ._SENT The_DT absence_NN of_IN reactivity_NN in_IN those_DT spots_NNS was_VBD assessed_VBN as_IN a_DT negative_JJ result_NN ._SENT Analysis_NN of_IN results_NNS ._SENT |_SYM Prevalence_NN was_VBD defined_VBN as_IN the_DT number_NN of_IN skin_NN snip-positive_NN (_( MFD_NP >_SYM 0_CD )_) and_CC DBA-positive_JJ (_( by_IN visual_JJ examination_NN )_) individuals_NNS in_IN each_DT locality_NN studied_VBD ._SENT The_DT sensitivity_NN and_CC positive_JJ predictive_JJ values_NNS of_IN the_DT PakF-DBA_NP were_VBD calculated_VBN by_IN comparison_NN to_TO the_DT skin_NN snip_NN as_IN a_DT "_`` gold_JJ standard_NN ._SENT "_`` Sensitivity_NN was_VBD calculated_VBN as_IN the_DT proportion_NN of_IN positive_JJ individuals_NNS detected_VBN by_IN both_DT methods_NNS to_TO those_DT detected_VBN by_IN the_DT skin_NN snip_NN test_NN ._SENT Similarly_RB ,_, the_DT positive_JJ and_CC negative_JJ predictive_JJ values_NNS were_VBD calculated_VBN as_IN the_DT proportions_NNS of_IN positive_JJ and_CC negative_JJ individuals_NNS by_IN both_DT methods_NNS to_TO those_DT positive_JJ or_CC negative_JJ by_IN DBA_NP ._SENT Statistics_NNS ._SENT |_SYM Pearson_NP 's_POS correlation_NN coefficients_NNS (_( Pcc_NP )_) were_VBD used_VBN to_TO compare_VB the_DT prevalences_NNS of_IN the_DT skin_NN snip_NN test_NN and_CC PakF-DBA_NP ,_, and_CC the_DT significance_NN was_VBD tested_VBN using_VBG the_DT Fisher_NP z_NN transformation_NN ._SENT FIG._NN 1_CD ._SENT |_SYM (_( A_NP )_) Reproducibility_NN in_IN the_DT production_NN of_IN PakF_NP ._SENT (_( A_NP )_) Reproducibility_NN in_IN the_DT production_NN of_IN PakF_NP ._SENT Lanes_NNS 1_CD to_TO 4_CD show_NN the_DT electrophoretic_JJ patterns_NNS of_IN PakF_NP fractions_NNS obtained_VBN at_IN different_JJ times_NNS ,_, showing_VBG the_DT mixture_NN of_IN at_IN least_JJS five_CD distinct_JJ bands_NNS that_WDT can_MD be_VB detected_VBN by_IN silver_NN staining_VBG ._SENT (_( B_LS )_) Clear-cut_JJ difference_NN between_IN positive_JJ (_( +_SYM )_) and_CC negative_JJ (_( -_: )_) samples_NNS in_IN the_DT PakF-DBA_NP test_NN ._SENT In_IN a_DT typical_JJ onchocerciasis-positive_JJ sample_NN ,_, the_DT two_CD spots_NNS where_WRB PakF_NP had_VBD been_VBN adsorbed_VBN ,_, as_RB well_RB as_IN the_DT procedural_JJ control_NN (_( TSF_NP )_) ,_, are_VBP recognized_VBN by_IN the_DT serum_NN sample_NN ._SENT Negative_JJ samples_NNS do_VBP not_RB show_VB reactivity_NN against_IN PakF_NP ,_, although_IN they_PP may_MD still_RB react_VB against_IN some_DT proteins_NNS present_JJ in_IN the_DT whole_JJ soluble_JJ extract_NN ,_, TSF_NP ._SENT (_( C_LS )_) Graphic_JJ representation_NN of_IN the_DT densitometric_JJ data_NNS obtained_VBN by_IN measuring_VBG the_DT densities_NNS of_IN the_DT spots_NNS in_IN all_PDT the_DT individual_JJ DBA_NP strips_NNS representing_VBG the_DT five_CD localities_NNS under_IN study_NN ._SENT A_DT line_NN at_IN 0.1_CD U_NN of_IN integrated_JJ intensity_NN indicates_VBZ the_DT cutoff_NN value_NN for_IN visually_RB negative_JJ samples_NNS ._SENT Skin_NN snip_NN test_NN results_NNS ._SENT |_SYM Of_IN the_DT 150_CD individuals_NNS tested_VBN ,_, 99_CD were_VBD skin_NN snip_NN positive_JJ and_CC 51_CD were_VBD skin_NN snip_NN negative_JJ ._SENT A_DT cluster_NN of_IN 40_CD negative_JJ individuals_NNS was_VBD found_VBN in_IN the_DT age_NN range_NN 5_CD to_TO 20_CD years_NNS ,_, and_CC the_DT remaining_JJ 11_CD were_VBD distributed_VBN between_IN 21-_CD and_CC 60-year-olds_NNS ._SENT No_DT Streptocerca_NP mf_NN were_VBD detected_VBN in_IN the_DT skin_NN snips_VBZ of_IN any_DT of_IN the_DT participants_NNS in_IN the_DT study_NN ._SENT The_DT prevalence_NN of_IN individuals_NNS with_IN mf+_JJ skin_NN snips_NNS varied_VBN from_IN 43.3_CD to_TO 76.7_CD %_NN in_IN the_DT five_CD localities_NNS ._SENT A_DT closer_JJR evaluation_NN of_IN the_DT <18-year-old_JJ age_NN group_NN shows_VBZ that_IN only_RB one_CD of_IN the_DT 15_CD individuals_NNS in_IN LOC2_NP had_VBD a_DT positive_JJ skin_NN test_NN ,_, resulting_VBG in_IN a_DT prevalence_NN of_IN 6.7_CD %_NN ._SENT In_IN this_DT age_NN group_NN ,_, the_DT highest_JJS prevalence_NN was_VBD in_IN locality_NN LOC3_NP ._SENT DBA_NP results_NNS ._SENT |_SYM Figure_NN shows_VBZ the_DT reproducibilities_NNS in_IN the_DT production_NN of_IN PakF_NP at_IN different_JJ times_NNS ._SENT Figure_NN shows_VBZ the_DT result_NN of_IN a_DT positive_JJ DBA_NP test_NN ._SENT For_IN a_DT sample_NN to_TO be_VB DBA_NP positive_NN ,_, the_DT two_CD dots_NNS where_WRB PakF_NP has_VBZ been_VBN adsorbed_VBN need_NN to_TO show_VB reactivity_NN ._SENT TSF_NP ,_, included_VBD as_IN a_DT procedural_JJ control_NN ,_, may_MD or_CC not_RB be_VB reactive_JJ depending_VBG on_IN the_DT degree_NN of_IN cross-reactivity_NN of_IN the_DT proteins_NNS in_IN the_DT whole_JJ soluble_JJ extract_NN ._SENT In_IN the_DT case_NN of_IN onchocerciasis_NN ,_, infected_JJ individuals_NNS normally_RB recognize_VBP TSF_NP even_RB if_IN they_PP do_VBP not_RB recognize_VB PakF_NP ,_, as_IN they_PP may_MD react_VB to_TO other_JJ proteins_NNS present_JJ in_IN the_DT whole_JJ extract_NN ._SENT In_IN order_NN to_TO represent_VB these_DT results_NNS in_IN a_DT more_RBR graphic_JJ manner_NN ,_, densitometric_JJ values_NNS were_VBD generated_VBN for_IN each_DT sample_NN ,_, obtaining_VBG the_DT mean_NN of_IN the_DT integrated_JJ intensity_NN of_IN each_DT pair_NN of_IN spots_NNS on_IN each_DT DBA_NP strip_NN ._SENT Using_VBG this_DT system_NN ,_, we_PP were_VBD able_JJ to_TO assign_VB a_DT numeric_JJ value_NN of_IN intensity_NN to_TO spots_NNS which_WDT were_VBD visually_RB weak_JJ or_CC very_RB weak_JJ ._SENT Those_DT visually_RB negative_JJ fell_VBD in_IN the_DT intensity_NN range_NN of_IN 0_CD to_TO 0.1_CD ,_, and_CC those_DT visually_RB positive_JJ had_VBD an_DT integrated_JJ intensity_NN above_IN 0.1_CD ._SENT This_DT allowed_VBD us_PP to_TO generate_VB a_DT graph_NN of_IN integrated_JJ intensities_NNS for_IN the_DT entire_JJ study_NN population_NN ._SENT Figures_NNS and_CC show_VB the_DT results_NNS obtained_VBN by_IN DBA_NP in_IN all_PDT the_DT areas_NNS under_IN study_NN ._SENT While_IN the_DT individual_JJ intensities_NNS of_IN the_DT spots_NNS varied_VBD ,_, there_EX was_VBD a_DT clear-cut_JJ difference_NN between_IN positive_JJ and_CC negative_JJ controls_NNS ._SENT In_IN total_NN ,_, 125_CD samples_NNS were_VBD positive_JJ by_IN DBA_NP and_CC 25_CD were_VBD negative_JJ ,_, with_IN a_DT cluster_NN of_IN 22_CD DBA-negative_JJ samples_NNS within_IN the_DT age_NN range_NN 5_CD to_TO 17_CD years_NNS ._SENT Individual_JJ analysis_NN of_IN each_DT locality_NN showed_VBD that_IN the_DT majority_NN of_IN positive_JJ individuals_NNS in_IN the_DT age_NN range_NN 5_CD to_TO 17_CD years_NNS were_VBD inhabitants_NNS of_IN the_DT villages_NNS grouped_VBN as_IN LOC3_NP and_CC those_DT from_IN LOC5_NP ._SENT The_DT MFD_NN in_IN relation_NN to_TO age_NN followed_VBD a_DT distribution_NN pattern_NN very_RB similar_JJ to_TO that_DT of_IN the_DT DBA_NP versus_IN age_NN (_( not_RB shown_VBN )_) ._SENT Comparison_NN of_IN DBA_NP and_CC skin_NN snip_NN results_NNS ._SENT |_SYM Tables_NP and_CC show_VB the_DT comparisons_NNS of_IN the_DT DBA_NP and_CC the_DT skin_NN snip_NN test_NN results_NNS ,_, using_VBG visual_JJ assessment_NN of_IN the_DT strips_NNS ,_, for_IN the_DT whole_JJ study_NN population_NN and_CC those_DT aged_VBN 5_CD to_TO 17_CD years_NNS ,_, respectively_RB ._SENT Stratified_VBN by_IN age_NN ,_, the_DT results_NNS clearly_RB show_VBP that_IN the_DT DBA_NP results_NNS closely_RB followed_VBD the_DT skin_NN snip_NN results_NNS in_IN all_DT age_NN groups_NNS ._SENT However_RB ,_, the_DT DBA_NP consistently_RB showed_VBD more_JJR positive_JJ individuals_NNS in_IN all_DT groups_NNS except_IN the_DT older_JJR age_NN groups_NNS ,_, with_IN the_DT biggest_JJS discrepancy_NN between_IN the_DT DBA_NP and_CC skin_NN snip_NN test_NN seen_VBN in_IN the_DT younger_JJR age_NN groups_NNS ._SENT A_DT closer_JJR look_NN at_IN the_DT 5-to-17-year-old_JJ age_NN group_NN in_IN the_DT individual_JJ localities_NNS showed_VBD a_DT similar_JJ trend_NN between_IN the_DT DBA_NP and_CC skin_NN snip_NN test_NN ,_, with_IN LOC2_NN having_VBG the_DT lowest_JJS DBA_NP positivity_NN but_CC LOC5_NP showing_VBG DBA_NP prevalence_NN akin_JJ to_TO that_DT of_IN LOC3_NP ._SENT The_DT PakF-DBA_NP detected_VBD more_JJR positive_JJ individuals_NNS than_IN the_DT skin_NN snip_NN test_NN ._SENT Moreover_RB ,_, 98_CD out_IN of_IN the_DT 99_CD skin_NN snip-positive_JJ individuals_NNS were_VBD detected_VBN by_IN DBA_NP ,_, for_IN a_DT sensitivity_NN of_IN 99_CD %_NN and_CC a_DT predictive_JJ value_NN of_IN 78_CD %_NN ._SENT A_DT positive_JJ correlation_NN (_( Pcc_NP =_SYM 0.899_CD ;_: P_NN <_0.05) 0.05_CD )_) ._SENT There_EX was_VBD no_DT significant_JJ correlation_NN (_( r_LS =_SYM 0.102_CD ;_: P_NN >_SYM 0.05_CD )_) between_IN the_DT prevalences_NNS estimated_VBN by_IN the_DT two_CD methods_NNS among_IN those_DT older_JJR than_IN 18_CD years_NNS ._SENT Cross-reactivity_NN of_IN PakF-DBA_NP with_IN other_JJ filarial_JJ sera_NN ._SENT |_SYM The_DT specificity_NN of_IN the_DT PakF-DBA_NP was_VBD assessed_VBN using_VBG sera_NN from_IN Indian_JJ individuals_NNS with_IN bancroftian_JJ infection_NN with_IN apparently_RB no_DT exposure_NN to_TO O._NP volvulus_NN ._SENT None_NN of_IN the_DT W._NP bancrofti_NN mf+_NN sera_NN or_CC the_DT control_NN sera_NN were_VBD positive_JJ by_IN DBA_NP ._SENT However_RB ,_, two_CD CP_NP and_CC two_CD EN_NN sera_NN reacted_VBD positively_RB on_IN the_DT DBA_NP ._SENT Pooled_VBN Guatemalan_JJ mf+_NN and_CC nonexposed_JJ sera_NN ,_, used_VBN as_IN positive_JJ and_CC negative_JJ controls_NNS ,_, were_VBD positive_JJ and_CC negative_JJ ,_, respectively_RB ,_, when_WRB tested_VBN at_IN the_DT same_JJ dilution_NN ._SENT In_IN total_NN ,_, 4_CD out_IN of_IN 40_CD Indian_JJ sera_NN were_VBD positive_JJ by_IN DBA_NP ,_, resulting_VBG in_IN a_DT 90_CD %_NN specificity_NN of_IN the_DT assay_NN ._SENT FIG._NN 2_CD ._SENT |_SYM DBA_NP results_NNS obtained_VBN from_IN serum_NN eluted_VBN from_IN finger_NN prick_NN blood_NN ,_, using_VBG PakF_NP as_IN an_DT antigen_NN ._SENT DBA_NP results_NNS obtained_VBN from_IN serum_NN eluted_VBN from_IN finger_NN prick_NN blood_NN ,_, using_VBG PakF_NP as_IN an_DT antigen_NN ._SENT Each_DT strip_NN represents_VBZ an_DT individual_JJ serum_NN ._SENT The_DT picture_NN shows_VBZ the_DT immune_JJ reactivity_NN of_IN each_DT individual_NN to_TO duplicate_VB spots_NNS of_IN PakF_NP (_( top_NN )_) and_CC the_DT unfractionated_JJ TSF_NP (_( bottom_NN )_) ._SENT The_DT samples_NNS are_VBP from_IN LOC1_NP ,_, but_CC the_DT last_JJ two_CD strips_NNS correspond_VBP to_TO a_DT pool_NN of_IN mf+_NN (_( GUmf+_NP )_) and_CC nonexposed_JJ (_( N-GU_NP )_) controls_VBZ ,_, respectively_RB ._SENT The_DT strips_NNS were_VBD visually_RB scored_VBN as_IN positive_JJ (_( +_SYM )_) or_CC negative_JJ (_( -_: )_) as_RB indicated_VBD in_IN the_DT legend_NN to_TO Fig._NN ._SENT FIG._NN 3_CD ._SENT |_SYM DBA_NP results_NNS from_IN LOC2_NP ,_, LOC3_NP ,_, LOC4_NP ,_, and_CC LOC5_NP ._SENT DBA_NP results_NNS from_IN LOC2_NP ,_, LOC3_NP ,_, LOC4_NP ,_, and_CC LOC5_NP ._SENT Visual_JJ assessment_NN of_IN the_DT DBA_NP strips_NNS was_VBD performed_VBN as_IN indicated_VBN in_IN the_DT legend_NN to_TO Fig._NN ._SENT FIG._NN 4_CD ._SENT |_SYM Specificity_NP of_IN PakF-DBA_NP ._SENT Specificity_NN of_IN PakF-DBA_NP ._SENT The_DT graphic_JJ representation_NN of_IN densitometric_JJ data_NNS shows_VBZ that_IN the_DT PakF-DBA_NP is_VBZ highly_RB specific_JJ when_WRB sera_NN from_IN individuals_NNS with_IN other_JJ filarial_JJ infections_NNS ,_, other_JJ than_IN onchocerciasis_NN ,_, are_VBP analyzed_VBN ._SENT Two_CD W._NP bancrofti_NP CP_NP and_CC two_CD EN_NNS were_VBD positive_JJ by_IN PakF-DBA_NP ,_, whereas_IN none_NN of_IN the_DT microfilaremic_JJ (_( MF_NP )_) individuals_NNS reacted_VBD to_TO PakF_NP ._SENT Pools_NNS of_IN Guatemalan_JJ O._NP volvulus-infected_NP (_( GUmf+_NP )_) and_CC nonexposed_JJ (_( N-GU_NP )_) samples_NNS were_VBD used_VBN as_IN positive_JJ and_CC negative_JJ controls_NNS ,_, respectively_RB ._SENT Visual_JJ assessment_NN :_: samples_NNS classed_VBN as_IN negative_JJ had_VBD an_DT integrated_JJ intensity_NN of_IN <0.1_U, 0.1_CD U._NP TABLE_NP 1_CD |_SYM Comparison_NN of_IN PakF-DBA_NP and_CC skin_NN snip_NN test_NN in_IN diagnosis_NN of_IN onchocerciasis_NN in_IN different_JJ age_NN ranges_NNS TABLE_NP 2_CD |_SYM Performance_NN of_IN PakF-DBA_NP compared_VBN to_TO skin_VB snip_NN test_NN for_IN diagnosis_NN of_IN onchocerciasis_NN in_IN the_DT whole_JJ study_NN population_NN (_( 5_CD to_TO 78_CD years_NNS old_JJ )_) TABLE_NP 3_CD |_SYM Performance_NN of_IN PakF-DBA_NP compared_VBN to_TO skin_VB snip_NN test_NN for_IN diagnosis_NN of_IN onchocerciasis_NN in_IN the_DT age_NN range_NN 5_CD to_TO 17_CD years_NNS Since_IN the_DT advent_NN of_IN successful_JJ control_NN of_IN onchocerciasis_NN through_IN measures_NNS including_VBG mass_JJ distribution_NN of_IN ivermectin_NN ,_, the_DT need_NN for_IN developing_VBG surveillance_NN programs_NNS to_TO detect_VB recrudescence_NN of_IN infection_NN in_IN the_DT OCP_NP area_NN ,_, as_RB well_RB as_IN safe_JJ ,_, inexpensive_JJ ,_, and_CC rapid_JJ diagnostic_JJ tests_NNS for_IN O._NP volvulus_NN infection_NN ,_, has_VBZ been_VBN highlighted_VBN ._SENT In_IN the_DT present_JJ study_NN ,_, we_PP have_VBP evaluated_VBN the_DT performance_NN of_IN a_DT simple_JJ DBA_NP (_( PakF-DBA_NP )_) as_IN a_DT serious_JJ contender_NN in_IN the_DT quest_NN for_IN a_DT less_RBR invasive_JJ and_CC more_RBR sensitive_JJ method_NN to_TO detect_VB O._NP volvulus_NN infection_NN in_IN areas_NNS with_IN diverse_JJ endemicities_NNS ._SENT With_IN the_DT PakF-DBA_NP ,_, we_PP were_VBD able_JJ to_TO detect_VB a_DT trend_NN similar_JJ to_TO that_DT of_IN the_DT skin_NN snip_NN test_NN ,_, but_CC the_DT PakF-DBA_NP detected_VBD a_DT higher_JJR proportion_NN of_IN infected_JJ individuals_NNS than_IN the_DT skin_NN snip_NN test_NN ._SENT These_DT included_VBD 98_CD out_NN of_IN 99_CD detected_VBN by_IN the_DT more_RBR invasive_JJ gold_NN standard_NN test_NN ._SENT This_DT could_MD indicate_VB that_IN the_DT sensitivity_NN of_IN the_DT DBA_NP described_VBD here_RB is_VBZ higher_JJR than_IN that_DT achieved_VBN with_IN the_DT skin_NN snip_NN test_NN ._SENT Although_IN we_PP have_VBP used_VBN analytical_JJ densitometry_NN to_TO generate_VB comprehensive_JJ graphs_NNS ,_, we_PP have_VBP shown_VBN that_IN the_DT results_NNS obtained_VBN by_IN visual_JJ examination_NN of_IN the_DT DBA_NP strips_NNS correspond_VBP well_RB with_IN densitometric_JJ data_NNS (_( Guzman_NP et_FW al._FW ,_, submitted_VBN )_) ._SENT The_DT clear-cut_JJ difference_NN between_IN positive_JJ and_CC negative_JJ samples_NNS allows_VBZ for_IN visual_JJ assessment_NN instead_RB of_IN the_DT use_NN of_IN a_DT sophisticated_JJ apparatus_NN such_JJ as_IN a_DT densitometer_NN ._SENT This_DT is_VBZ of_IN particular_JJ interest_NN in_IN areas_NNS where_WRB the_DT use_NN of_IN delicate_JJ or_CC sophisticated_JJ readout_NN devices_NNS is_VBZ not_RB practical_JJ ._SENT Therefore_RB ,_, the_DT visual_JJ results_NNS of_IN the_DT DBA_NP strips_NNS were_VBD enough_JJ to_TO establish_VB a_DT correlation_NN between_IN the_DT prevalences_NNS estimated_VBN by_IN the_DT skin_NN snip_NN test_NN and_CC those_DT estimated_VBN by_IN DBA_NP in_IN all_DT age_NN groups_NNS ._SENT The_DT fact_NN that_IN the_DT DBA_NP results_NNS were_VBD comparable_JJ to_TO those_DT obtained_VBN by_IN skin_NN snip_NN tests_NNS indicates_VBZ the_DT possibility_NN that_IN the_DT overall_JJ estimates_NNS of_IN prevalence_NN generated_VBN by_IN DBA_NP from_IN a_DT sentinel_NN population_NN could_MD replace_VB those_DT generated_VBN by_IN skin_NN snips_NNS ._SENT The_DT major_JJ difference_NN in_IN the_DT number_NN of_IN positive_JJ individuals_NNS detected_VBN by_IN DBA_NP and_CC skin_NN snip_NN test_NN was_VBD observed_VBN in_IN the_DT groups_NNS aged_VBD 5_CD to_TO 17_CD years_NNS ._SENT When_WRB analyzed_VBD separately_RB ,_, a_DT positive_JJ and_CC significant_JJ correlation_NN between_IN the_DT prevalences_NNS estimated_VBN with_IN the_DT PakF-DBA_NP and_CC the_DT skin_NN snip_NN test_NN was_VBD found_VBN for_IN the_DT population_NN aged_VBD 5_CD to_TO 17_CD years_NNS ._SENT However_RB ,_, no_DT such_JJ correlation_NN was_VBD observed_VBN in_IN the_DT group_NN of_IN adults_NNS studied_VBN (_( >17_JJ years_NNS old_JJ )_) ._SENT Due_JJ to_TO the_DT long_JJ life_NN span_NN of_IN the_DT adult_JJ worms_NNS ,_, the_DT continuous_JJ exposure_NN in_IN areas_NNS with_IN ongoing_JJ transmission_NN of_IN onchocerciasis_NN ,_, and_CC the_DT unknown_JJ duration_NN of_IN circulation_NN of_IN antibodies_NNS against_IN the_DT proteins_NNS contained_VBN in_IN PakF_NP ,_, it_PP is_VBZ not_RB likely_JJ that_IN an_DT antibody-based_JJ assay_NN like_IN the_DT PakF-DBA_NP would_MD show_VB a_DT better_JJR performance_NN than_IN the_DT skin_NN snip_NN test_NN when_WRB an_DT age_NN group_NN of_IN >20_JJ years_NNS is_VBZ selected_VBN as_IN a_DT sentinel_NN population_NN to_TO assess_VB the_DT efficacy_NN of_IN control_NN measures_NNS ._SENT Our_PP$ results_NNS are_VBP in_IN accordance_NN with_IN those_DT of_IN other_JJ studies_NNS that_WDT have_VBP shown_VBN that_IN the_DT most_RBS useful_JJ indicator_NN group_NN for_IN detecting_VBG recrudescence_NN ,_, as_RB well_RB as_RB for_IN determining_VBG the_DT intensity_NN of_IN infection_NN in_IN a_DT community_NN ,_, is_VBZ the_DT population_NN 5_CD to_TO 15_CD years_NNS of_IN age_NN ._SENT The_DT PakF-DBA_NP may_MD be_VB positive_JJ in_IN more_JJR specimens_NNS due_JJ to_TO a_DT number_NN of_IN reasons_NNS ,_, including_VBG higher_JJR sensitivity_NN ,_, lower_JJR specificity_NN ,_, or_CC the_DT capacity_NN to_TO detect_VB even_RB early_JJ (_( prepatent_JJ )_) infection_NN ._SENT The_DT possibility_NN of_IN detecting_VBG prepatent_JJ disease_NN can_MD only_RB be_VB evaluated_VBN in_IN long-term_JJ longitudinal_JJ studies_NNS ._SENT Our_PP$ results_NNS suggest_VBP that_IN the_DT PakF-DBA_NP has_VBZ a_DT higher_JJR sensitivity_NN coupled_VBN with_IN high_JJ specificity_NN ._SENT There_EX is_VBZ an_DT emphasis_NN in_IN the_DT World_NP Health_NP Organization_NP strategy_NN on_IN the_DT need_NN for_IN surveillance_NN methods_NNS to_TO be_VB highly_RB specific_JJ even_RB at_IN the_DT cost_NN of_IN low_JJ sensitivity_NN ._SENT The_DT problem_NN of_IN specificity_NN is_VBZ that_IN of_IN the_DT quality_NN of_IN the_DT gold_JJ standard_NN ._SENT If_IN the_DT gold_JJ standard_NN has_VBZ low_JJ sensitivity_NN ,_, then_RB assays_VBZ with_IN higher_JJR sensitivities_NNS can_MD be_VB viewed_VBN as_IN having_VBG low_JJ specificities_NNS ._SENT This_DT is_VBZ the_DT problem_NN with_IN the_DT highly_RB specific_JJ but_CC low-sensitivity_NN skin_NN snip_NN test_NN ._SENT However_RB ,_, we_PP have_VBP previously_RB established_VBN the_DT specificity_NN of_IN the_DT PakF-DBA_NP assay_NN to_TO be_VB 100_CD %_NN using_VBG a_DT panel_NN of_IN sera_NN from_IN noninfected_JJ individuals_NNS from_IN areas_NNS where_WRB no_DT other_JJ filaria_NN is_VBZ present_JJ (_( Guatemala_NP ,_, in_IN Central_NP America_NP )_) (_( Guzman_NP et_FW al._FW ,_, submitted_VBN )_) ._SENT In_IN the_DT later_JJR studies_NNS ,_, we_PP used_VBD sera_NN from_IN individuals_NNS infected_VBN with_IN other_JJ coendemic_JJ parasites_NNS in_IN the_DT area_NN ,_, mainly_RB Ascaris_NP lumbricoides_NNS ,_, in_IN order_NN to_TO rule_VB out_RP any_DT cross-reactivity_NN due_JJ to_TO the_DT carbohydrate-containing_NN antigens_NNS widely_RB shared_VBN among_IN nematodes_NNS ,_, primarily_RB phosphocholine-containing_VBG antigens_NNS ._SENT In_IN addition_NN ,_, we_PP ruled_VBD out_RP cross-reactivity_NN with_IN a_DT series_NN of_IN sera_NN from_IN filaria-infected_JJ patients_NNS ._SENT In_IN the_DT present_JJ study_NN ,_, we_PP have_VBP also_RB approached_VBN this_DT question_NN by_IN extending_VBG the_DT pool_NN of_IN test_NN samples_NNS with_IN well-characterized_JJ sera_NN from_IN individuals_NNS with_IN other_JJ filarial_JJ infections_NNS from_IN areas_NNS where_WRB onchocerciasis_NN is_VBZ not_RB endemic_JJ ._SENT The_DT sensitivity_NN of_IN the_DT PakF-DBA_NP using_VBG these_DT sera_NN was_VBD 90_CD %_NN ._SENT Of_IN importance_NN ,_, however_RB ,_, is_VBZ the_DT fact_NN that_IN those_DT positive_NN in_IN the_DT PakF-DBA_NP were_VBD not_RB the_DT individuals_NNS with_IN circulating_VBG bancroftian_JJ mf_NN ,_, for_IN whom_WP nine_CD of_IN nine_CD sera_NN were_VBD negative_JJ by_IN the_DT PakF-DBA_NP test_NN ._SENT Combined_JJ analysis_NN using_VBG the_DT present_JJ data_NNS and_CC the_DT additional_JJ panels_NNS of_IN sera_NN from_IN areas_NNS where_WRB other_JJ filarias_NNS ,_, but_CC not_RB O._NP volvulus_NN ,_, are_VBP endemic_JJ resulted_VBN in_IN 96_CD %_NN specificity_NN (_( Guzman_NP et_FW al._FW ,_, submitted_VBN )_) ._SENT These_DT results_NNS also_RB suggest_VBP that_IN the_DT PakF-DBA_NP could_MD be_VB useful_JJ in_IN screening_VBG children_NNS and_CC adolescents_NNS born_VBN after_IN control_NN measures_NNS have_VBP been_VBN established_VBN ,_, since_IN they_PP form_VBP a_DT desirable_JJ sentinel_NN population_NN to_TO detect_VB recrudescence_NN of_IN infection_NN in_IN controlled_JJ areas_NNS ._SENT In_IN the_DT areas_NNS of_IN endemicity_NN ,_, the_DT need_NN for_IN assays_NNS that_WDT provide_VBP rapid_JJ results_NNS is_VBZ advocated_VBN ._SENT The_DT time_NN needed_VBD to_TO obtain_VB qualitative_JJ results_NNS from_IN the_DT PakF-DBA_NP was_VBD comparable_JJ to_TO that_DT for_IN the_DT rapid_JJ version_NN of_IN the_DT skin_NN snip_NN test_NN ,_, i.e._FW ,_, 3_CD h._NNS Thus_RB ,_, although_IN a_DT quantification_NN of_IN the_DT level_NN of_IN infection_NN is_VBZ beyond_IN the_DT capabilities_NNS of_IN the_DT DBA_NP ,_, in_IN terms_NNS of_IN a_DT rapid_JJ assessment_NN for_IN surveillance_NN purposes_NNS ,_, it_PP represents_VBZ an_DT affordable_JJ alternative_NN that_WDT offers_VBZ more_JJR sensitivity_NN than_IN the_DT skin_NN snip_NN test_NN ._SENT Moreover_RB ,_, the_DT test_NN can_MD be_VB performed_VBN using_VBG only_RB a_DT few_JJ drops_NNS of_IN finger_NN prick_NN blood_NN ,_, and_CC this_DT represents_VBZ an_DT advantage_NN in_IN terms_NNS of_IN a_DT higher_JJR compliance_NN from_IN the_DT individuals_NNS in_IN areas_NNS under_IN constant_JJ screening_NN to_TO evaluate_VB the_DT impact_NN of_IN control_NN measures_NNS ._SENT Several_JJ promising_JJ diagnostic_JJ methods_NNS ,_, based_VBN on_IN detection_NN of_IN specific_JJ antibodies_NNS ,_, parasite_NN DNA_NN ,_, or_CC parasite_NN antigens_NNS in_IN clinical_JJ specimens_NNS ,_, have_VBP been_VBN developed_VBN for_IN onchocerciasis_NN in_IN recent_JJ years_NNS ._SENT However_RB ,_, none_NN of_IN these_DT have_VBP been_VBN implemented_VBN under_IN field_NN conditions_NNS in_IN the_DT areas_NNS of_IN endemicity_NN ._SENT Antibody_NN tests_NNS using_VBG recombinant_JJ antigens_NNS have_VBP been_VBN based_VBN on_IN standard_JJ ,_, indirect_JJ enzyme-linked_JJ immunosorbent_JJ assays_NNS ,_, which_WDT can_MD be_VB performed_VBN in_IN a_DT simple_JJ laboratory_NN ._SENT The_DT antigen_NN and_CC DNA_NN detection_NN methods_NNS are_VBP performed_VBN over_IN 2_CD or_CC 3_CD days_NNS ,_, and_CC they_PP require_VBP more_JJR ,_, in_IN terms_NNS of_IN laboratory_NN infrastructure_NN ,_, equipment_NN ,_, and_CC expensive_JJ reagents_NNS ,_, than_IN the_DT enzyme-linked_JJ immunosorbent_JJ assay_NN ._SENT In_IN either_DT case_NN ,_, the_DT costs_NNS involved_VBN in_IN both_CC the_DT acquisition_NN of_IN instrumentation_NN and_CC the_DT transfer_NN of_IN the_DT technology_NN are_VBP not_RB trivial_JJ ,_, thus_RB making_VBG the_DT development_NN of_IN less_JJR expensive_JJ ,_, stable_JJ ,_, and_CC reliable_JJ methods_NNS a_DT necessity_NN in_IN low-income_JJ countries_NNS where_WRB onchocerciasis_NN is_VBZ being_VBG controlled_VBN or_CC still_RB exists_VBZ ._SENT Simple_JJ yet_CC reliable_JJ approaches_NNS like_IN the_DT use_NN of_IN a_DT less_RBR expensive_JJ diagnostic_JJ technique_NN that_WDT could_MD be_VB implemented_VBN under_IN field_NN conditions_NNS are_VBP of_IN particular_JJ importance_NN ,_, especially_RB when_WRB the_DT successor_NN to_TO OCP_NP ,_, the_DT African_JJ Program_NN of_IN Onchocerciasis_NP Control_NP ,_, is_VBZ facing_VBG funding_VBG difficulties_NNS which_WDT could_MD threaten_VB its_PP$ future_JJ success_NN ._SENT The_DT PakF-DBA_NP described_VBD here_RB ,_, unlike_IN antigen_NN and_CC DNA_NN detection_NN methods_NNS ,_, does_VBZ not_RB require_VB pretreatment_NN of_IN samples_NNS or_CC expensive_JJ supplies_NNS and_CC equipment_NN (_( e.g._FW ,_, PCR_NP )_) ._SENT We_PP have_VBP evaluated_VBN the_DT PakF-DBA_NP in_IN heat-inactivated_JJ eluted_VBN sera_NN (_( 56C_NP ;_: 30_CD min_NN )_) and_CC found_VBD no_DT difference_NN in_IN intensity_NN between_IN heated_JJ and_CC unheated_JJ sera_NN (_( data_NNS not_RB shown_VBN )_) ._SENT In_IN addition_NN ,_, we_PP have_VBP observed_VBN that_IN PakF_NP is_VBZ highly_RB stable_JJ at_IN working_VBG temperatures_NNS normally_RB found_VBD in_IN the_DT areas_NNS of_IN endemicity_NN ,_, and_CC it_PP does_VBZ not_RB require_VB the_DT use_NN of_IN anti-immunoglobulin_NP G4_NP conjugates_VBZ to_TO reduce_VB the_DT background_NN ,_, since_IN the_DT molecules_NNS comprising_VBG PakF_NP do_VBP not_RB seem_VB to_TO be_VB recognized_VBN by_IN such_PDT an_DT isotype_NN (_( Guzman_NP et_FW al._FW ,_, submitted_VBN )_) ._SENT A_DT possible_JJ disadvantage_NN ,_, compared_VBN to_TO antigen_NN or_CC DNA_NN detection_NN methods_NNS ,_, is_VBZ that_IN the_DT PakF-DBA_NP does_VBZ not_RB distinguish_VB between_IN past_JJ and_CC present_JJ infections_NNS ,_, but_CC this_DT is_VBZ a_DT problem_NN of_IN all_DT antibody-based_JJ assays_NNS ._SENT Nevertheless_RB ,_, the_DT PakF-DBA_NP may_MD still_RB be_VB a_DT suitable_JJ tool_NN for_IN following_VBG changes_NNS in_IN transmission_NN when_WRB used_VBN in_IN younger_JJR age_NN groups_NNS ._SENT Furthermore_RB ,_, antibody_NN testing_NN still_RB holds_VBZ great_JJ promise_NN as_IN a_DT means_NN for_IN monitoring_VBG changes_NNS in_IN the_DT transmission_NN of_IN O._NP volvulus_NN after_IN mass_JJ treatment_NN of_IN populations_NNS ._SENT Criticisms_NNS of_IN the_DT use_NN of_IN native_JJ human-derived_JJ material_NN in_IN the_DT PakF-DBA_NP have_VBP previously_RB been_VBN made_VBN in_IN terms_NNS of_IN reproducibility_NN of_IN material_NN and_CC safety_NN ._SENT We_PP have_VBP made_VBN many_JJ preparations_NNS of_IN PakF_NP ,_, and_CC the_DT reproducibility_NN in_IN performance_NN in_IN the_DT DBA_NP has_VBZ been_VBN high_JJ ._SENT A_DT reliable_JJ ,_, sensitive_JJ ,_, and_CC specific_JJ recombinant_JJ protein_NN would_MD be_VB valuable_JJ ,_, but_CC in_IN its_PP$ absence_NN ,_, native_JJ proteins_NNS still_RB have_VBP a_DT role_NN ._SENT Where_WRB the_DT question_NN of_IN possible_JJ exposure_NN to_TO contaminant_NN viruses_NNS is_VBZ concerned_VBN ,_, PakF_NP ,_, which_WDT is_VBZ a_DT protein_NN fraction_NN stable_JJ at_IN high_JJ temperatures_NNS ,_, may_MD be_VB heat_NN treated_VBN before_IN use_NN (_( Guzman_NP et_FW al._FW ,_, submitted_VBN )_) ._SENT In_IN addition_NN ,_, the_DT PakF-DBA_NP can_MD be_VB used_VBN with_IN heat-inactivated_JJ sera_NN ._SENT Concern_NN about_IN the_DT availability_NN of_IN parasite_NN material_NN to_TO prepare_VB PakF_NP is_VBZ justified_VBN ._SENT However_RB ,_, in_IN areas_NNS where_WRB no_DT control_NN measures_NNS have_VBP been_VBN established_VBN ,_, the_DT relative_JJ abundance_NN of_IN nodules_NNS from_IN which_WDT the_DT worms_NNS are_VBP freed_VBN makes_VBZ it_PP possible_JJ to_TO obtain_VB large_JJ amounts_NNS of_IN PakF_NP to_TO be_VB used_VBN in_IN rapid_JJ screening_NN of_IN sentinel_NN populations_NNS ._SENT In_IN our_PP$ hands_NNS ,_, the_DT amount_NN of_IN TSF_NP obtained_VBD from_IN a_DT batch_NN of_IN one_CD to_TO three_CD worms_NNS is_VBZ enough_JJ to_TO run_VB a_DT HiTrap-Q_NP column_NN up_RB to_TO 10_CD times_NNS ._SENT Each_DT purification_NN round_NN produces_VBZ 350_CD mul_NN of_IN PakF_NP that_WDT can_MD be_VB applied_VBN to_TO nitrocellulose_NN strips_NNS without_IN further_JJR treatment_NN ._SENT The_DT yield_NN after_IN 10_CD purification_NN rounds_NNS (_( 3.5_CD ml_NN )_) allows_VBZ the_DT analysis_NN of_IN at_IN least_JJS 3,000_CD samples_NNS ,_, using_VBG the_DT format_NN of_IN duplicate_JJ PakF_NP spots_NNS per_IN strip_NN ._SENT Even_RB if_IN the_DT format_NN is_VBZ changed_VBN to_TO use_VB 1_CD mul_NN per_IN spot_NN ,_, the_DT number_NN of_IN samples_NNS that_WDT could_MD be_VB tested_VBN is_VBZ large_JJ enough_RB ,_, considering_VBG that_IN the_DT material_NN comes_VBZ from_IN only_RB one_CD to_TO three_CD worms_NNS ._SENT In_IN the_DT areas_NNS of_IN endemicity_NN ,_, where_WRB nodulectomy_NN is_VBZ a_DT common_JJ practice_NN not_RB only_RB for_IN control_NN but_CC also_RB for_IN aesthetic_JJ purposes_NNS ,_, the_DT availability_NN of_IN worms_NNS for_IN PakF_NP production_NN would_MD not_RB be_VB an_DT insurmountable_JJ difficulty_NN ._SENT We_PP and_CC others_NNS have_VBP shown_VBN variations_NNS in_IN the_DT protein_NN compositions_NNS of_IN O._NP volvulus_NN parasites_NNS from_IN different_JJ geographic_JJ areas_NNS ._SENT However_RB ,_, we_PP have_VBP prepared_VBN PakF_NP from_IN worms_NNS isolated_VBN in_IN both_DT Ghana_NP and_CC Guatemala_NP ,_, used_VBD it_PP in_IN crossed_VBN analysis_NN with_IN sera_NN from_IN the_DT two_CD countries_NNS ,_, and_CC obtained_VBD similar_JJ results_NNS regardless_RB of_IN the_DT origin_NN of_IN the_DT parasite_NN material_NN (_( Guzman_NP et_FW al._FW ,_, submitted_VBN )_) ._SENT Therefore_RB ,_, geographical_JJ variations_NNS would_MD not_RB be_VB of_IN concern_NN in_IN screening_VBG a_DT particular_JJ area_NN with_IN parasite_NN material_NN obtained_VBN from_IN worms_NNS from_IN another_DT region_NN ._SENT In_IN conclusion_NN ,_, the_DT present_JJ study_NN provides_VBZ evidence_NN that_IN it_PP is_VBZ still_RB possible_JJ to_TO implement_VB simple_JJ techniques_NNS for_IN the_DT monitoring_NN of_IN onchocerciasis_NNS which_WDT offer_VBP high_JJ sensitivity_NN and_CC specificity_NN while_IN being_VBG affordable_JJ in_IN financially_RB challenged_VBN areas_NNS ._SENT Where_WRB costs_NNS are_VBP an_DT issue_NN ,_, and_CC in_IN the_DT absence_NN of_IN more_JJR elaborate_JJ diagnostic_JJ tests_NNS in_IN the_DT areas_NNS of_IN endemicity_NN ,_, simple_JJ tests_NNS like_IN the_DT PakF-DBA_NP could_MD still_RB deliver_VB reliable_JJ information_NN that_WDT can_MD be_VB used_VBN to_TO monitor_VB changes_NNS in_IN the_DT transmission_NN of_IN onchocerciasis_NN ._SENT 